Patties' shrinking pie

Weakness in the company's frozen fruit business contributed to a sharp fall in net profit for the full year, but underlying performance met expectations.

Frozen foods company Patties Foods (PFL) has lost its sweet tooth as weakness in its desserts products contribute to a sharp drop in full-year profit.

Management had to write down $11.8 million in its frozen fruit business as the category struggled with stiff competition from private label offerings and increased discounts at supermarkets.

The company has also been plagued by problems with its newly installed robotic packaging system and management may dump its frozen fruit business as it embarks on a “strategic review” for the division.

Net profit plunged 75.4% to $4.8 million even as sales inched up 3.8% to $244.8 million for the year ended June 30, 2013, and the news sent the stock falling 2.8% this morning to $1.41 before it recovered to trade flat at $1.45.

While the weak profit is disconcerting, Patties underlying performance met expectations. The company posted a 10.6% drop in underlying earnings before interest tax, depreciation and amortisation (EBITDA) to $34.6 million thanks to ongoing growth in its savoury pie division, which includes well-known brands like Four’n Twenty and Patties.

Management is also counting on a new brand launch, Herbert Adams, to drive further growth. The new brand will appeal to growing demand for gourmet pies.

Patties is also looking to a new range of frozen doughnut desserts under its Nana’s brand to help turnaround the performance of its desserts business.

The stock, which is part of the Uncapped 100, has fallen around 11% over the past year.

InvestSMART FORUM: Come and meet the team

We're loading up the van and going on tour from April to June, with events on the NSW central & north coast, the QLD mid-north coast and in Perth, Adelaide, Melbourne, Sydney and Canberra. Come and meet the team and take home simple strategies that you can use to build an investment portfolio to weather any storm. Book your spot here.

Want access to our latest research and new buy ideas?

Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.

Sign up for free

Related Articles